AHA GUIDELINES Bundle (free trial)

2017 Update Incorporated - Valvular Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/362033

Contents of this Issue

Navigation

Page 52 of 63

53 Table 37. Pregnancy and VHD Recommendations COR LOE Native Valve Stenosis All patients with suspected valve stenosis should undergo a clinical evaluation and TTE before pregnancy. I C All patients with severe valve stenosis (stages C and D) should undergo prepregnancy counseling by a cardiologist with expertise in managing patients with VHD during pregnancy. I C All patients referred for a valve operation before pregnancy should receive prepregnancy counseling by a cardiologist with expertise in managing patients with VHD during pregnancy about the risks and benefits of all options for operative interventions, including mechanical prosthesis, bioprosthesis, and valve repair. I C Pregnant patients with severe valve stenosis (stages C and D) should be monitored in a tertiary care center with a dedicated Heart Valve Team of cardiologists, surgeons, anesthesiologists, and obstetricians with expertise in the management of high- risk cardiac patients during pregnancy. I C Exercise testing is reasonable in asymptomatic patients with severe AS (aortic velocity ≥4.0 m/s or ΔPmean ≥40 mm Hg, stage C) before pregnancy. IIa C Medical erapy Anticoagulation should be given to pregnant patients with MS and AF unless contraindicated. I C Use of beta blockers as required for rate control is reasonable for pregnant patients with MS in the absence of contraindication if tolerated. IIa C Use of diuretics may be reasonable for pregnant patients with MS and HF symptoms (stage D). IIb C ACE inhibitors and ARBs should NOT be given to pregnant patients with valve stenosis. III: Harm B Intervention Valve intervention is recommended before pregnancy for symptomatic patients with severe AS (aortic velocity ≥4.0 m/s or ΔPmean ≥40 mm Hg, stage D). I C Valve intervention is recommended before pregnancy for symptomatic patients with severe MS (MVA ≤1.5 cm 2 , stage D). I C PMBC is recommended before pregnancy for asymptomatic patients with severe MS (MVA ≤1.5 cm 2 , stage C) who have valve morpholog y favorable for PMBC. I C Valve intervention is reasonable before pregnancy for asymptomatic patients with severe AS (aortic velocity ≥4.0 m/s or ΔPmean ≥40 mm Hg, stage C). IIa C

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - 2017 Update Incorporated - Valvular Heart Disease